Compound ID | 574
Class: Quinolone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Institute where first reported: | Procter and Gamble Pharmaceuticals |
| Year first mentioned: | 1999 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Procter and Gamble Pharmaceuticals seems to have withdrawn from antibiotic R&D |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/273122356 |
| Citations: |
|